Orchestra BioMed (OBIO) vs Scribe Therapeutics (SCTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Orchestra BioMed is the larger company by market cap ($342.0 million vs $324.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OBIO | SCTX |
|---|---|---|
| Share price | $5.69 | $17.16 |
| Market cap | $342.03M | $324.87M |
| 1-day change | +0.54% | -2.32% |
| YTD return | +36.39% | — |
| 1-year return | +107.33% | — |
| 5-year return | -42.54% | — |
| EPS (TTM) | $-0.86 | $-3.84 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.50 | $39.60 |
| 52-week low | $2.78 | $13.50 |
| Distance from 52-week high | -12.45% | -56.67% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +118.43% | +232.17% |
| Average volume | 299.24K | 357.50K |
| Shares outstanding | 60.11M | 18.93M |
| Employees | 86 | 82 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Orchestra BioMed
OBIO stock →Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States.
Health Care · Medicinal Chemicals and Botanical Products · 86 employees
About Scribe Therapeutics
SCTX stock →Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 82 employees
OBIO vs SCTX FAQ
Which is bigger, Orchestra BioMed or Scribe Therapeutics?
Orchestra BioMed (OBIO) is larger, with a market capitalization of $342.03M compared with $324.87M for Scribe Therapeutics (SCTX).
Are Orchestra BioMed and Scribe Therapeutics in the same industry?
Both are in the Health Care sector, but in different industries: Medicinal Chemicals and Botanical Products for Orchestra BioMed and Biotechnology: Biological Products (No Diagnostic Substances) for Scribe Therapeutics.